Reduced Birth Weight and Exposure to Per- and Polyfluoroalkyl Substances: A Review of Possible Underlying Mechanisms Using the AOP-HelpFinder

• Published in: Toxics (Basel) Vol. 10; no. 11; p. 684
• Main Authors: Gundacker, Claudia, Audouze, Karine, Widhalm, Raimund, Granitzer, Sebastian, Forsthuber, Martin, Jornod, Florence, Wielsøe, Maria, Long, Manhai, Halldórsson, Thórhallur Ingi, Uhl, Maria, Bonefeld-Jørgensen, Eva Cecilie
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.11.2022; MDPI
• Subjects: Adipocytes; Adipogenesis; Adipose tissue; Birth size; Birth weight; Births; Endocrine system; Environmental aspects; Exposure; fetal growth; Fetus; Fetuses; Gene expression; Gestational age; Growth; Health aspects; Histology; Hormones; In vivo methods and tests; Insulin-like growth factors; Investigations; Organ weight; Oxidative stress; PCB; Perfluoroalkyl & polyfluoroalkyl substances; Peroxisome proliferator-activated receptors; PFDA; PFHxS; PFNA; PFOA; PFOS; Polychlorinated biphenyls; Preeclampsia; Pregnant women; Prenatal experience; Reactive oxygen species; Receptors; Review; Signal transduction; Signaling; Stillbirth; Thyroid; Thyroid hormones; Weight reduction; Womens health; Xenoestrogens; Austria; United States > US
• ISSN: 2305-6304; 2305-6304
• DOI: 10.3390/toxics10110684

Prenatal exposure to per- and polyfluorinated substances (PFAS) may impair fetal growth. Our knowledge of the underlying mechanisms is incomplete. We used the Adverse Outcome Pathway (AOP)-helpFinder tool to search PubMed for studies published until March 2021 that examined PFAS exposure in relation to birth weight, oxidative stress, hormones/hormone receptors, or growth signaling pathways. Of these 1880 articles, 106 experimental studies remained after abstract screening. One clear finding is that PFAS are associated with oxidative stress in in vivo animal studies and in vitro studies. It appears that PFAS-induced reactive-oxygen species (ROS) generation triggers increased peroxisome proliferator-activated receptor (PPAR)γ expression and activation of growth signaling pathways, leading to hyperdifferentiation of pre-adipocytes. Fewer proliferating pre-adipocytes result in lower adipose tissue weight and in this way may reduce birth weight. PFAS may also impair fetal growth through endocrine effects. Estrogenic effects have been noted in in vivo and in vitro studies. Overall, data suggest thyroid-damaging effects of PFAS affecting thyroid hormones, thyroid hormone gene expression, and histology that are associated in animal studies with decreased body and organ weight. The effects of PFAS on the complex relationships between oxidative stress, endocrine system function, adipogenesis, and fetal growth should be further explored.